Fosrenol Post-marketing Surveillance for Hemodialysis in Japan
Status:
Completed
Trial end date:
2019-05-28
Target enrollment:
Participant gender:
Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local
prospective and observational study of patients in hemodialysis who received Fosrenol for
hyperphosphatemia. The objective of this study is to assess safety and efficacy of using
Fosrenol in clinical practice. A total 3,000 patients will be recruited and followed 5 years.